NCT01103492View on ClinicalTrials.gov

Treatment of Hemorrhagic Radiation Proctitis Using the Halo System

NACompletedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Pelvic Neoplasms

Interventions

DEVICE

HALO90 Ablation catheter

FDA approved endoscopic device for use in coagulation of tissue in the digestive tract using radiofrequency energy.

Trial Locations (1)

44106

University Hospitals Case Medical Center, Cleveland

Sponsors

Collaborators (1)

Covidien, GI Solutions

All Listed Sponsors

collaborator

Covidien, GI Solutions

INDUSTRY

lead

University Hospitals Cleveland Medical Center

OTHER

NCT01103492 - Treatment of Hemorrhagic Radiation Proctitis Using the Halo System | Biotech Hunter | Biotech Hunter